Texas Permanent School Fund Sells 1,194 Shares of Encompass Health Co. (NYSE:EHC)

Texas Permanent School Fund decreased its stake in shares of Encompass Health Co. (NYSE:EHCGet Rating) by 1.7% in the first quarter, Holdings Channel.com reports. The fund owned 70,535 shares of the company’s stock after selling 1,194 shares during the period. Texas Permanent School Fund’s holdings in Encompass Health were worth $5,016,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of the stock. State Street Corp boosted its holdings in shares of Encompass Health by 1.2% during the 4th quarter. State Street Corp now owns 2,602,750 shares of the company’s stock valued at $170,580,000 after purchasing an additional 29,795 shares during the last quarter. Invesco Ltd. lifted its position in Encompass Health by 14.0% during the fourth quarter. Invesco Ltd. now owns 1,389,517 shares of the company’s stock valued at $90,679,000 after purchasing an additional 170,155 shares during the last quarter. Schroder Investment Management Group grew its stake in shares of Encompass Health by 10.9% in the 4th quarter. Schroder Investment Management Group now owns 1,285,026 shares of the company’s stock worth $83,861,000 after buying an additional 126,158 shares in the last quarter. Geode Capital Management LLC grew its position in Encompass Health by 0.8% in the fourth quarter. Geode Capital Management LLC now owns 1,229,108 shares of the company’s stock worth $80,211,000 after acquiring an additional 9,359 shares in the last quarter. Finally, Dimensional Fund Advisors LP raised its position in Encompass Health by 19.2% during the fourth quarter. Dimensional Fund Advisors LP now owns 1,209,928 shares of the company’s stock valued at $78,964,000 after purchasing an additional 194,667 shares during the period. 91.70% of the stock is owned by hedge funds and other institutional investors.

Encompass Health Trading Up 0.1 %

EHC opened at $52.91 on Friday. The company has a quick ratio of 1.26, a current ratio of 1.24 and a debt-to-equity ratio of 1.29. The stock’s fifty day moving average is $54.14 and its two-hundred day moving average is $62.81. The company has a market capitalization of $5.28 billion, a P/E ratio of 16.18, a PEG ratio of 2.54 and a beta of 0.91. Encompass Health Co. has a 52 week low of $44.33 and a 52 week high of $81.45.

Encompass Health (NYSE:EHCGet Rating) last released its quarterly earnings data on Monday, August 1st. The company reported $0.89 earnings per share for the quarter, missing analysts’ consensus estimates of $0.97 by ($0.08). The business had revenue of $1.33 billion during the quarter, compared to analysts’ expectations of $1.34 billion. Encompass Health had a return on equity of 16.20% and a net margin of 6.22%. The firm’s revenue was up 3.3% compared to the same quarter last year. During the same period last year, the company earned $1.17 earnings per share. Analysts forecast that Encompass Health Co. will post 2.84 earnings per share for the current year.

Encompass Health Cuts Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, October 17th. Investors of record on Monday, October 3rd will be given a dividend of $0.15 per share. This represents a $0.60 dividend on an annualized basis and a yield of 1.13%. The ex-dividend date of this dividend is Friday, September 30th. Encompass Health’s payout ratio is currently 34.25%.

Analysts Set New Price Targets

A number of equities analysts have recently commented on EHC shares. Barclays dropped their target price on Encompass Health from $80.00 to $63.00 and set an “overweight” rating for the company in a report on Thursday. Stephens cut their price objective on shares of Encompass Health from $78.00 to $74.00 and set an “overweight” rating on the stock in a research report on Tuesday, June 21st. Royal Bank of Canada lowered their target price on shares of Encompass Health from $85.00 to $82.00 in a report on Wednesday, June 8th. Raymond James cut their price target on shares of Encompass Health from $70.00 to $65.00 and set a “strong-buy” rating on the stock in a report on Thursday. Finally, BMO Capital Markets decreased their price objective on shares of Encompass Health from $83.00 to $65.00 and set an “outperform” rating for the company in a research note on Thursday. One equities research analyst has rated the stock with a hold rating, eight have given a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Buy” and an average target price of $74.60.

Encompass Health Profile

(Get Rating)

Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates in two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.

See Also

Want to see what other hedge funds are holding EHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Encompass Health Co. (NYSE:EHCGet Rating).

Institutional Ownership by Quarter for Encompass Health (NYSE:EHC)

Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.